Clinical Potential of Agents That Affect Thrombin Signaling in Degenerative and Traumatic Neurologic Disorders
Reference144 articles.
1. Akiyama, H., Ikeda, K., Kondo, H., and McGeer, P. L. (1992) Thrombin accumulation in brains of patients with Alzheimer’ s disease. Neurosci. Lett. 146, 152–154. 2. Andrew, M., Schmidt, B., Mitchell, L., Paes, B., and Ofosu, F. (1990) Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb. Haemost. 63, 27–30. 3. Baker, J. B., Knauer, D. J., and Cunningham, D. D. (1986) Protease nexins: secreted protease inhibitors that regulate protease actions at and near the cell surface, in The Receptors ( Conn, P. M., ed.). Academic Press, New York, pp. 153–172. 4. Baker, J. B., Low, D. A., Simmer, R. L., and Cunningham, D. D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37–45. 5. Bancroft, J. D., McDowell, S. A., and Degen, S. J. F. (1992) The human prothrombin gene: transcriptional regulation in HepG2 cells. Biochemistry 31, 12469–12476.
|
|